創薬・開発における人工知能

alt text
発表者:
Gary An, Prof. & Vice Chair of Surgical Research
University of Vermont, University of Vermont
Aaron K. Sato, CSO
Twist Bioscience, Twist Bioscience
Enkelejda Miho, Prof. of Digital Life Sciences
The FHNW University of Applied Sciences and Arts Northwestern Switzerland, The FHNW University of Applied Sciences and Arts Northwestern Switzerland

このウェビナーでわかること
人工知能や機械学習などの新しい技術が精密医療にどのような影響を及ぼすか
生体における潜在的な標的を見つけるために、AI の力をどのように活用できるか
Twist Bioscience により、創薬プロセスはどのように加速するか

​​​​​​In the era of precision medicine, how can the power of AI be utilised to turn biological studies into the best possible targets? How can AI be applied to systems biology to bring the most effective targets to light? And how can we use these insights in the drug discovery process?

In the webinar, 4 different experts will discuss the areas in which AI is bringing biological insights to the forefront, and Aaron Sato, Twist's CSO, will explain how Twist is enabling  the key players to write the Future of Biologics with Synthetic DNA and Machine Learning.

発表者:

  • Gary An, Prof. & Vice Chair of Surgical Research, University of Vermont

  • Aaron K. Sato, CSO, Twist Bioscience

  • Enkelejda Miho, Prof. of Digital Life Sciences, The FHNW University of Applied Sciences and Arts Northwestern Switzerland

  • Philip Kim, Prof., The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto

ウェビナーを視聴するために、
お客様情報をご記入ください。

 

 

Powered by Translations.com GlobalLink Web Software